The collaboration is designed to bridge a critical funding gap by connecting the nation’s life sciences innovators directly with Wholesale Investor’s extensive network of over 45,000 high-net-worth, family office, and professional investors.
The partnership addresses a well-defined challenge in the Australian market: while the nation produces world-class research and innovation, early-stage and scaling companies often struggle to access the private capital required to navigate crucial phases of development, clinical trials, and commercialisation.
This initiative will leverage MTPConnect’s deep sector expertise and ecosystem network with Wholesale Investor’s proven capital-raising platform and investor network.
The cornerstone of the partnership will be the Life Sciences Investor Day, a premier showcase event that will be held as the dedicated Day 1 of Wholesale Investor’s annual Emergence 2026 Conference in Sydney in February.
MTPConnect CEO, Stuart Dignam, says the program is all about doing more to back life sciences startups and SMEs through the difficult early years of innovation.
“Our mission is to foster the growth and global competitiveness of Australia’s vibrant life sciences sector. Access to capital is a critical component of this mission. By partnering with Wholesale Investor, we are creating a vital new pathway for companies to connect with potential investors and delivering a program of support that will assist them to become Investor Ready,” said Mr Dignam.
Wholesale Investor Founder Steve Torso commented that the partnership is a solution for investors and innovators.
“This partnership is about creating a more efficient and intelligent market. We are breaking down the barriers between Australia’s world-class innovators and the private capital essential for their growth. By combining MTPConnect’s unparalleled sector knowledge with our CapitalHQ platform, we can provide our investor network with potential new life science investment opportunities while giving life sciences companies the tools and access they need to succeed. The showcase at Emergence 2026 will be a pivotal moment for the entire industry,” said Mr Torso.
The program will formally launch this month with an Information Session: Raising Capital in 2026 on 15 October 2025 at 5:00pm AEDT and a call to Register Interest, culminating with the Life Sciences Investor Day scheduled for 18 February 2026.